Our ISO 14971 risk management services support medical device manufacturers in developing compliant risk management processes, risk management files, and documentation aligned with ISO 14971:2019 and EU MDR requirements. Patient Guard provides expert guidance to ensure risks are identified, evaluated, controlled, and monitored throughout the device lifecycle.
ISO 14971 is the internationally recognised standard for applying risk management to medical devices. It provides a structured approach for identifying hazards, estimating and evaluating risks, implementing risk controls, and monitoring residual risk.
Risk management is a core requirement for medical device compliance and must be integrated with technical documentation, clinical evaluation, post-market surveillance, usability, and design and development processes.
Patient Guard acts as your medical device risk management consultancy partner, supporting the development, review, and maintenance of compliant risk management documentation aligned with ISO 14971:2019, EU MDR, UK MDR, and Notified Body expectations.
Without a robust risk management process, manufacturers risk non-conformities, regulatory delays, and weaknesses in technical documentation submissions.
Patient Guard provides expert ISO 14971 risk management services tailored to your device type, classification, intended use, and lifecycle stage.
This page explains Patient Guard’s ISO 14971 Risk Management services, helping manufacturers develop compliant Risk Management Plans, Risk Management Files and Risk Management Reports throughout the medical device lifecycle. If you're looking for a broader introduction to ISO 14971, including hazard identification, risk analysis, risk evaluation, risk control, benefit-risk analysis and post-production monitoring, read our Complete Guide to ISO 14971 Risk Management.
We don't create over-complicated, theoretical risk matrix policies. We focus on lean, practical risk management frameworks that genuinely improve your product safety without stalling development.
Our team ensures your ISO 14971 processes integrate flawlessly with your wider QMS, including clinical evaluation (CEP/CER) and post-market surveillance data loops.
With an extensive track record defending risk architecture to major Notified Bodies, we build and remediate files to ensure you clear your submissions with complete confidence.
We build comprehensive, audit-ready Risk Management Files from scratch or reconstruct legacy documentation to maintain seamless regulatory alignment.
Our experts facilitate systematic Hazard Identification and Failure Mode and Effects Analysis (FMEA) to pinpoint potential product vulnerabilities early.
We draft robust, evidence-backed Risk-Benefit Evaluations showing clinical advantages definitively outweigh any overall residual device risks.
We align your technical risk data tightly with EU MDR General Safety and Performance Requirements (GSPRs) and technical file structures.
We close the loop between your QMS and production data, establishing proactive links to feed real-world field complaints back into your risk files.
ISO 14971:2019 requires manufacturers to establish a risk management process covering:
A compliant risk management file is essential for demonstrating device safety, regulatory compliance, and ongoing lifecycle control.
We assess your device, intended use, classification, and existing documentation to develop a risk management strategy and plan
We identify hazards, evaluate risks, define risk controls, and support benefit-risk justifications
We prepare the Risk Management Report and align outputs with PMS, PMCF, clinical evaluation, and technical documentation
We support ISO 14971 risk management services across:
ph
Ensure medical device safety and regulatory compliance with expert ISO 14971 risk management support. Patient Guard develops compliant risk management plans, risk analyses, and risk management reports aligned with EU MDR, UKCA, and global regulatory expectations.
Assess device intended use, classification, and existing documentation to develop the Risk Management Plan and strategy
Identify hazards, perform risk analysis, evaluate risks, and define appropriate risk control measures
Prepare the Risk Management Report and align outputs with CER, PMS, PMCF, and technical documentation requirements
ISO 14971 is the international standard for applying risk management to medical devices throughout the product lifecycle.
ISO 14971 is widely recognised as the key standard for medical device risk management and is commonly expected for EU MDR, UKCA, and global regulatory submissions.
A risk management file typically includes the Risk Management Plan, risk analysis, risk evaluation, risk controls, benefit-risk analysis, residual risk evaluation, and Risk Management Report.
EU MDR requires manufacturers to reduce risks as far as possible, evaluate benefit-risk, and maintain risk management throughout the device lifecycle. ISO 14971 provides the accepted framework for meeting these expectations.
Yes, Patient Guard can review, update, and remediate existing risk management files to address gaps, Notified Body findings, or regulatory changes.
Click on the links below to discover more:
This page explains Patient Guard’s ISO 14971 Risk Management services for medical device manufacturers. If you're looking for a broader understanding of the EU Medical Device Regulation (MDR), including General Safety and Performance Requirements (GSPRs), CE marking, Technical Documentation, Clinical Evaluation, Post-Market Surveillance and the legal role of risk management throughout the device lifecycle, read our MDR for Beginners – Complete Guide.
This page explains Patient Guard’s ISO 14971 Risk Management services for both medical device and IVD manufacturers. If you're developing an in vitro diagnostic medical device, read our IVDR for Beginners – A Comprehensive Guide to understand the requirements of Regulation (EU) 2017/746, including Risk Management, Performance Evaluation, Technical Documentation, Quality Management Systems and Post-Market Performance Follow-up (PMPF).
This page explains Patient Guard’s ISO 14971 Risk Management services for medical device manufacturers. Risk management is a fundamental requirement of an ISO 13485 Quality Management System and should be integrated throughout the entire product lifecycle. To learn how ISO 13485 incorporates risk management into design, manufacturing, supplier control, production and post-market activities, read our Complete Guide to ISO 13485.
This page explains Patient Guard’s ISO 14971 Risk Management services for medical device manufacturers. Risk management and validation work together to demonstrate that medical devices are safe, effective and fit for their intended purpose. To learn more about design validation, process validation, software validation, usability validation and regulatory expectations throughout the product lifecycle, read our Complete Guide to Medical Device Validation.
This page explains Patient Guard’s ISO 14971 Risk Management services for medical device manufacturers. Biological evaluation forms an essential part of the overall risk management process for devices with direct or indirect patient contact. To learn how ISO 10993 supports biological risk assessment, Biological Evaluation Plans (BEPs), Biological Evaluation Reports (BERs), biocompatibility and toxicological assessment, read our Complete Guide to Biological Evaluation of Medical Devices.
This page explains Patient Guard’s ISO 14971 Risk Management services for medical device manufacturers. Risk management and clinical evaluation work together to demonstrate that a medical device is safe, performs as intended and delivers an acceptable benefit-risk profile throughout its lifecycle. To learn more about Clinical Evaluation Plans (CEPs), Clinical Evaluation Reports (CERs), benefit-risk assessment, State of the Art (SOTA) and Post-Market Clinical Follow-up (PMCF), read our Complete Guide to Medical Device Clinical Evaluation.
A complete guide to NHS DTAC compliance for digital health manufacturers, covering the five DTAC assessment areas, required evidence, clinical safety, data protection, technical security, interoperability and usability, and how to prepare your digital health technology for NHS procurement.
Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.
Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.
Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.
Performance Evaluation is one of the most important requirements under the EU In Vitro Diagnostic Regulation (IVDR). Every manufacturer must demonstrate that their in vitro diagnostic medical device achieves its intended purpose through robust scientific validity, analytical performance and clinical performance evidence. This guide explains every stage of IVDR Performance Evaluation, including Performance Evaluation Plans (PEPs), Performance Evaluation Reports (PERs), Post-Market Performance Follow-up (PMPF) and how Performance Evaluation supports successful CE marking under Regulation (EU) 2017/746.
Understanding how your in vitro diagnostic device is classified under the EU IVDR is one of the first and most important steps towards regulatory compliance. This guide explains the IVDR classification rules, the differences between Class A, B, C and D IVDs, how Annex VIII is applied, and how classification affects conformity assessment, technical documentation and Notified Body involvement.
Speak to one of our regulatory and compliance experts to arrange an obligation-free call. Our experienced team is ready to help you get your medical device to market.
UK Office
Thank you! The checklist is now ready to download.
